55296-17-8 Usage
Description
3-AMINO-4-PHENYLAMINO-BENZOIC ACID, also known as 3-Amino-4-(phenylamino)benzoic Acid, is an organic compound with the CAS number 55296-17-8. It is characterized by its unique molecular structure, which features an amino group at the 3-position and a phenylamino group at the 4-position of the benzoic acid backbone. 3-AMINO-4-PHENYLAMINO-BENZOIC ACID has been identified for its potential applications in various fields, particularly in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
3-AMINO-4-PHENYLAMINO-BENZOIC ACID is used as a potent and selective human prostaglandin E2 receptor subtype 4 (hEP4-R) antagonist for the treatment of endometriosis. Endometriosis is a painful disorder in which tissue similar to the lining of the uterus grows outside the uterus, causing discomfort and other complications. By acting as an antagonist to the hEP4-R, this compound can help alleviate the symptoms and improve the quality of life for patients suffering from this condition.
Check Digit Verification of cas no
The CAS Registry Mumber 55296-17-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,2,9 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 55296-17:
(7*5)+(6*5)+(5*2)+(4*9)+(3*6)+(2*1)+(1*7)=138
138 % 10 = 8
So 55296-17-8 is a valid CAS Registry Number.
InChI:InChI=1/C13H12N2O2/c14-11-8-9(13(16)17)6-7-12(11)15-10-4-2-1-3-5-10/h1-8,15H,14H2,(H,16,17)
55296-17-8Relevant articles and documents
Structural Modifications of Benzimidazoles via Multi-Step Synthesis and Their Impact on Sirtuin-Inhibitory Activity
Yoon, Yeong Keng,Choon, Tan Soo
, p. 1 - 8 (2016/01/29)
Benzimidazole derivatives have been shown to possess sirtuin-inhibitory activity. In the continuous search for potent sirtuin inhibitors, systematic changes on the terminal benzene ring were performed on previously identified benzimidazole-based sirtuin i
AGENT FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH ACTIVITY OF NEUROTROPHIC FACTORS
-
, (2012/04/17)
A compound depicted by the formula below, or a pharmaceutically acceptable salt or solvate thereof. wherein, R1 represents (1) a C3-6 alkyl group,(2) a C1-6 alkyl group substituted with one or more substituent group(s) sel